Weight Loss Lowers Risk of Obesity-Related Cancer, Study Finds
HCPLive
JUNE 21, 2024
In retrospective, observational research at ADA 2024, real-world weight loss was linked to a reduction in the risk of obesity-related cancers.
Cancer Obesity Research 
80 
Circadian disruption, clock genes, and metabolic health
Journal of Clinical Investigation - Cardiology
JULY 15, 2024
A growing body of research has identified circadian-rhythm disruption as a risk factor for metabolic health. These circadian mechanisms represent potential pathophysiological pathways linking circadian disruption to adverse metabolic health outcomes, including obesity, metabolic syndrome, and type 2 diabetes.
Can the Recent Stanford Vegan vs. Omnivore Twin Study Inform Us about the “Optimal” Diet for Cardiometabolic Health?
Physiologically Speaking
DECEMBER 27, 2023
The quest to determine whether plant-based diets surpass omnivorous diets in their heart healthfulness has been ongoing for decades, yielding inconclusive results despite dedicated research endeavors. Recent research underscores the critical role of gene-nutrient interactions — so-called nutrigenomics.
Can the Recent Stanford Vegan vs. Omnivore Twin Study Inform Us about the “Optimal” Diet for Cardiometabolic Health?
Physiologically Speaking
DECEMBER 27, 2023
The quest to determine whether plant-based diets surpass omnivorous diets in their heart healthfulness has been ongoing for decades, yielding inconclusive results despite dedicated research endeavors. Recent research underscores the critical role of gene-nutrient interactions — so-called nutrigenomics.
FDA Approves Wegovy for Cardiovascular Risk Reduction in Adults with Known Heart Disease and Overweight or Obesity
DAIC
MARCH 8, 2024
Food and Drug Administration ( FDA ) has approved an additional indication for Wegovy ( semaglutide ) to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight along with a reduced calorie diet and increased physical activity.
The role of multimorbidity in patients with heart failure across the left ventricular ejection fraction spectrum: data from the Swedish Heart Failure Registry
European Journal of Heart Failure
DECEMBER 22, 2023
Obesity was associated with a lower risk of all-cause death (HR 0.81, 95%CI 0.79-0.84). CAD and valvular heart disease were associated with a higher risk of all-cause and CV mortality, but not non-CV mortality, whereas cancer and muscolo-skeletal disease increased the risk of non-CV mortality.
American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary
DAIC
FEBRUARY 29, 2024
Five highly-anticipated late-breaking clinical trial sessions, an ACC/AHA guidelines update session and a host of featured clinical research sessions have been announced by program planners for the American College of Cardiology’s 73 rd Annual Scientific Session & Expo to be held April 6-8 in Atlanta, GA. 12:15 p.m.
Let's personalize your content